Show simple item record

Diabetes and ischaemic stroke outcome

dc.contributor.authorMacDougal, E. L.
dc.contributor.authorHerman, W. H.
dc.contributor.authorWing, J. J.
dc.contributor.authorMorgenstern, L. B.
dc.contributor.authorLisabeth, L. D.
dc.date.accessioned2018-09-04T20:09:01Z
dc.date.available2019-11-01T15:10:32Zen
dc.date.issued2018-09
dc.identifier.citationMacDougal, E. L.; Herman, W. H.; Wing, J. J.; Morgenstern, L. B.; Lisabeth, L. D. (2018). "Diabetes and ischaemic stroke outcome." Diabetic Medicine 35(9): 1249-1257.
dc.identifier.issn0742-3071
dc.identifier.issn1464-5491
dc.identifier.urihttps://hdl.handle.net/2027.42/145551
dc.description.abstractAimTo compare all‐cause mortality, stroke recurrence and functional outcomes in people who have experienced stroke, with and without diabetes.MethodsWe captured data on population‐based ischaemic strokes (2006–2012) in Nueces County, Texas. Data were collected from participant interviews and medical records. Differences in cumulative mortality and stroke recurrence risk by diabetes status were estimated at 30 days and 1 year using Cox models. Differences in 90‐day functional outcomes (activities of daily living/instrumental activities of daily living score: range 1–4; higher scores worse) by diabetes status were assessed using Tobit regression. Effect modification by ethnicity was examined.ResultsThere were 1301 ischaemic strokes, 46% with history of known diabetes. The median (interquartile range) age was 70 (58–81) years and 61% were Mexican American. People with diabetes were younger and more likely to be Mexican American compared with those without diabetes. After adjustment, diabetes predicted mortality (30‐day hazard ratio 1.44, 95% CI 0.97–2.12; 1‐year hazard ratio 1.47, 95% CI 1.09–1.97) but not stroke recurrence (1‐year hazard ratio 1.27, 95% CI 0.78–2.07). People with diabetes had a worse functional outcome score that was explained by cardiovascular risk factors and pre‐stroke factors. Diabetes was not associated with functional outcome in the fully adjusted model (final adjusted activities of daily living/instrumental activities of daily living score difference 0.11, 95% CI –0.07 to 0.30). Effect modification by ethnicity was not significant (P>0.3 for all models).ConclusionsDiabetes was associated with higher mortality and worse functional outcome but not stroke recurrence. Interventions are needed to decrease the adverse outcomes associated with diabetes, particularly in Mexican‐American people.What’s new?Although diabetes is an established risk factor for incident ischaemic stroke, its role in stroke outcomes remains uncertain, with inconsistent findings across studies and limited data from diverse, population‐based studies.In our ethnically diverse population‐based study, we found that diabetes was associated with higher stroke mortality and worse functional outcome but not with stroke recurrence.Results suggest that interventions are needed to decrease the adverse stroke outcomes associated with diabetes, particularly in Mexican‐American people who experience a high prevalence of diabetes.
dc.publisherLawrence Erlbaum Associates
dc.publisherWiley Periodicals, Inc.
dc.titleDiabetes and ischaemic stroke outcome
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145551/1/dme13665_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145551/2/dme13665.pdf
dc.identifier.doi10.1111/dme.13665
dc.identifier.sourceDiabetic Medicine
dc.identifier.citedreferenceTobin J. Estimation of Relationships for Limited Dependent‐Variables. Econometrica 1958; 26: 24 – 36.
dc.identifier.citedreferenceKissela B, Lindsell CJ, Kleindorfer D, Alwell K, Moomaw CJ, Woo D et al. Clinical prediction of functional outcome after ischemic stroke: the surprising importance of periventricular white matter disease and race. Stroke 2009; 40: 530 – 536.
dc.identifier.citedreferenceMegherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 2003; 34: 688 – 694.
dc.identifier.citedreferenceLisabeth LD, Sanchez BN, Baek J, Skolarus LE, Smith MA, Garcia N et al. Neurological, functional, and cognitive stroke outcomes in Mexican Americans. Stroke 2014; 45: 1096 – 1101.
dc.identifier.citedreferenceGentile NT, Seftchick MW. Poor outcomes in Hispanic and African American patients after acute ischemic stroke: influence of diabetes and hyperglycemia. Ethn Dis 2008; 18: 330 – 335.
dc.identifier.citedreferenceKuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older mexican americans over a 7‐year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care 2003; 26: 3054 – 3060.
dc.identifier.citedreferenceTrevino FM, Moyer ME, Valdez RB, Stroup‐Benham CA. Health insurance coverage and utilization of health services by Mexican Americans, mainland Puerto Ricans, and Cuban Americans. JAMA 1991; 265: 233 – 237.
dc.identifier.citedreferenceMorgenstern LB, Smith MA, Sanchez BN, Brown DL, Zahuranec DB, Garcia N et al. Persistent ischemic stroke disparities despite declining incidence in Mexican Americans. Ann Neurol 2013; 74: 778 – 785.
dc.identifier.citedreferenceSmith MA, Risser JM, Lisabeth LD, Moye LA, Morgenstern LB. Access to care, acculturation, and risk factors for stroke in Mexican Americans: the Brain Attack Surveillance in Corpus Christi (BASIC) project. Stroke 2003; 34: 2671 – 2675.
dc.identifier.citedreferenceJorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross‐validation. Psychol Med 1994; 24: 145 – 153.
dc.identifier.citedreferenceWilliams LS, Yilmaz EY, Lopez‐Yunez AM. Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke 2000; 31: 858 – 862.
dc.identifier.citedreferenceShou J, Zhou L, Zhu S, Zhang X. Diabetes is an Independent Risk Factor for Stroke Recurrence in Stroke Patients: A Meta‐analysis. J Stroke Cerebrovasc Dis 2015; 24: 1961 – 1968.
dc.identifier.citedreferenceCohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
dc.identifier.citedreferenceKissela BM, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 2005; 28: 355 – 359.
dc.identifier.citedreferenceSacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology 1994; 44: 626 – 34.
dc.identifier.citedreferenceJia Q, Zhao X, Wang C, Wang Y, Yan Y, Li H et al. Diabetes and poor outcomes within 6 months after acute ischemic stroke: the China National Stroke Registry. Stroke 2011; 42: 2758 – 2762.
dc.identifier.citedreferenceGerman Stroke Study Collaboration. Predicting outcome after acute ischemic stroke: an external validation of prognostic models. Neurology 2004; 62: 581 – 585.
dc.identifier.citedreferenceAmerican Diabetes Association. Standards of medical care in diabetes–2013. Diabetes Care 2013; 36 ( Suppl 1 ): S11 – 66.
dc.identifier.citedreferenceFuentes B, Cruz‐Herranz A, Martinez‐Sanchez P, Rodriguez‐Sanz A, Ruiz Ares G, Prefasi D et al. Acute ischemic stroke patients with diabetes should not be excluded from intravenous thrombolysis. J Thromb Thrombolysis 2014; 38: 522 – 527.
dc.identifier.citedreferenceReeves MJ, Vaidya RS, Fonarow GC, Liang L, Smith EE, Matulonis R et al. Quality of care and outcomes in patients with diabetes hospitalized with ischemic stroke: findings from Get With the Guidelines‐Stroke. Stroke 2010; 41: e409 – 417.
dc.identifier.citedreferenceBenjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R et al. Heart Disease and Stroke Statistics‐2017 Update: A Report From the American Heart Association. Circulation 2017; 135: e146 – e603.
dc.identifier.citedreferenceOvbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA et al. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke 2013; 44: 2361 – 2375.
dc.identifier.citedreferenceCollaboration Emerging Risk Factors, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta‐analysis of 102 prospective studies. Lancet 2010; 375: 2215 – 2222.
dc.identifier.citedreferenceBoyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010; 8: 29.
dc.identifier.citedreferenceKaarisalo MM, Raiha I, Sivenius J, Immonen‐Raiha P, Lehtonen A, Sarti C et al. Diabetes worsens the outcome of acute ischemic stroke. Diabetes Res Clin Pract 2005; 69: 293 – 298.
dc.identifier.citedreferenceMarini C, Baldassarre M, Russo T, De Santis F, Sacco S, Ciancarelli I et al. Burden of first‐ever ischemic stroke in the oldest old: evidence from a population‐based study. Neurology 2004; 62: 77 – 81.
dc.identifier.citedreferenceWinell K, Paakkonen R, Pietila A, Reunanen A, Niemi M, Salomaa V. Prognosis of ischaemic stroke is improving similarly in patients with type 2 diabetes as in nondiabetic patients in Finland. Int J Stroke 2011; 6: 295 – 301.
dc.identifier.citedreferenceAndersen KK, Andersen ZJ, Olsen TS. Predictors of early and late case‐fatality in a nationwide Danish study of 26,818 patients with first‐ever ischemic stroke. Stroke 2011; 42: 2806 – 2812.
dc.identifier.citedreferenceHoward G, Toole JF, Becker C, Lefkowitz DS, Truscott BL, Rose L et al. Changes in survival following stroke in five North Carolina counties observed during two different periods. Stroke 1989; 20: 345 – 350.
dc.identifier.citedreferenceWang Z, Li J, Wang C, Yao X, Zhao X, Wang Y et al. Gender differences in 1‐year clinical characteristics and outcomes after stroke: results from the China National Stroke Registry. PloS One 2013; 8: e56459.
dc.identifier.citedreferenceAppelros P, Nydevik I, Viitanen M. Poor outcome after first‐ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke 2003; 34: 122 – 126.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.